{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:19:00Z","timestamp":1789600740522,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.clinthera.2009.05.017","type":"journal-article","created":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T08:41:52Z","timestamp":1245228112000},"page":"921-944","source":"Crossref","is-referenced-by-count":55,"title":["A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis"],"prefix":"10.1016","volume":"31","author":[{"given":"Claus","family":"Bachert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.05.017_bib1","first-page":"82","article-title":"Allergy prevalence survey by the World Allergy Organization","volume":"19","author":"Compalati","year":"2007","journal-title":"Allergy Clin Immunol Int: J World Allergy Org."},{"key":"10.1016\/j.clinthera.2009.05.017_bib2","first-page":"61","article-title":"Epidemiology of allergic rhinitis","volume":"Vol 31","author":"Sibbald","year":"1993"},{"key":"10.1016\/j.clinthera.2009.05.017_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","article-title":"Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials","volume":"93","author":"Juniper","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib4","series-title":"Presented at: 25th Congress of the European Academy of Allergology and Clinical Immunology","article-title":"Congestion and its impact on sleep in individuals with allergic rhinitis","author":"Shedden","year":"2006"},{"key":"10.1016\/j.clinthera.2009.05.017_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00151829-200504060-00007","article-title":"Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: Findings from a large online survey","volume":"4","author":"Shedden","year":"2005","journal-title":"Treat Respir Med."},{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.05.017_bib6","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 86","key":"10.1016\/j.clinthera.2009.05.017_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcrj.2005.11.002","article-title":"International Primary Care Respiratory Group (IPCRG) guidelines: Management of allergic rhinitis","volume":"15","author":"Price","year":"2006","journal-title":"Prim Care Respir J."},{"key":"10.1016\/j.clinthera.2009.05.017_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1081-1206(10)63155-9","article-title":"Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1254\/jphs.08037FP","article-title":"Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis","volume":"108","author":"Mahmoud","year":"2008","journal-title":"J Pharmacol Sci."},{"key":"10.1016\/j.clinthera.2009.05.017_bib11","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.2174\/138161208786369777","article-title":"Anti-inflammatory effects of H1-antihistamines: Clinical and immunological relevance","volume":"14","author":"Vena","year":"2008","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.clinthera.2009.05.017_bib12","series-title":"Clarinex (desloratadine) [package insert]","year":"2007"},{"key":"10.1016\/j.clinthera.2009.05.017_bib13","series-title":"Allegra (fexofenadine hydrochloride) [package insert]","year":"2007"},{"key":"10.1016\/j.clinthera.2009.05.017_bib14","series-title":"Xyzal (levocetirizine dihydrochloride) [package insert]","year":"2008"},{"key":"10.1016\/j.clinthera.2009.05.017_bib15","series-title":"Aerius (desloratadine) [package insert]","year":"2006"},{"key":"10.1016\/j.clinthera.2009.05.017_bib16","series-title":"Telfast (fexofenadine hydrochloride) [package insert]","year":"2007"},{"key":"10.1016\/j.clinthera.2009.05.017_bib17","series-title":"Xyzal (levocetirizine dihydrochloride) [package insert]","year":"2008"},{"key":"10.1016\/j.clinthera.2009.05.017_bib18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0091-6749(05)80156-3","article-title":"Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy","volume":"86","author":"Doyle","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1398-9995.1997.tb00970.x","article-title":"An approach to the understanding ofthe nasal early-phase reaction induced by nasal allergen challenge","volume":"52","author":"Wang","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjp.0706118","article-title":"Histamine receptors that influence blockage of the normal human nasal airway","volume":"144","author":"Taylor-Clark","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11882-007-0007-1","article-title":"Nasonasal reflexes, the nasal cycle, and sneeze","volume":"7","author":"Baraniuk","year":"2007","journal-title":"Curr Allergy Asthma Rep."},{"key":"10.1016\/j.clinthera.2009.05.017_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0091-6749(05)80223-4","article-title":"The role of histamine in allergic diseases","volume":"86","author":"White","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/0036554021000028116","article-title":"Effect of histamine on the permeability of the nasal mucosa in vivo","volume":"123","author":"Yang","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib24","doi-asserted-by":"crossref","first-page":"S599","DOI":"10.1067\/mai.2000.106885","article-title":"Unique mechanistic features of allergic rhinitis","volume":"105","author":"Togias","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000236855","article-title":"Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure","volume":"106","author":"Wang","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib26","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/S0091-6749(99)70308-8","article-title":"Pathophysiology of the inflammatory response","volume":"104","author":"Pearlman","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/00016489850183494","article-title":"Late phase response in nasal mucosa closely correlated with immediate phase reaction and hyperreactivity to histamine","volume":"118","author":"Terada","year":"1998","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1365-2222.2006.02544.x","article-title":"Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine","volume":"36","author":"Patou","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/000164801300102950","article-title":"Dual symptomatic and exudative nasal responses are not characteristics of perennial allergic rhinitis","volume":"121","author":"Andersson","year":"2001","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00130832-200406000-00005","article-title":"Control of nasal obstruction in perennial allergic rhinitis","volume":"4","author":"Wang","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2009.05.017_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2222.1999.00003.x-i2","article-title":"Development of T-cell memory against inhalant allergies: Risks for the future","volume":"29","author":"Holt","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00151829-200403010-00006","article-title":"Etiopathogenesis and management of perennial allergic rhinitis: A state-of-the-art review","volume":"3","author":"Bush","year":"2004","journal-title":"Treat Respir Med."},{"key":"10.1016\/j.clinthera.2009.05.017_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2500\/108854100778249088","article-title":"Allergic rhinitis update: Epidemiology and natural history","volume":"21","author":"Bellanti","year":"2000","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clinthera.2009.05.017_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM200101043440106","article-title":"Allergy and allergic diseases. First of two parts","volume":"344","author":"Kay","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2009.05.017_bib35","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1046\/j.1365-2222.2001.01130.x","article-title":"Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine","volume":"31","author":"Schroeder","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2222.1997.tb00745.x","article-title":"Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells","volume":"27","author":"Genovese","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0625.1995.tb00257.x","article-title":"Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarbo-ethoxyloratadine and dexamethasone by human mast and basophilic cell lines","volume":"4","author":"Lippert","year":"1995","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bjp.0707457","article-title":"Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells","volume":"152","author":"Holden","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00003088-200847040-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexo fenadine and levocetirizine: A comparative review","volume":"47","author":"Devillier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2009.05.017_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0378-4274(01)00510-0","article-title":"Cardiotoxicity of new antihistamines and cisapride","volume":"127","author":"Paakkari","year":"2002","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.clinthera.2009.05.017_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(99)00457-4","article-title":"Effects of terfenadine, astemi-zole and epinastine on electrocardiogram in conscious cynomolgus monkeys","volume":"378","author":"Ohmura","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib42","first-page":"841","article-title":"Executive summary of the workshop report. 7\u201310 December 1999, Geneva, Switzerland [published correction appears in Allergy. 2002; 57:1208]","volume":"57","author":"Bachert","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0002-9149(97)00634-6","article-title":"Electrocardiographic findings in patients with diphenhydramine overdose","volume":"80","author":"Zareba","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00003495-200565030-00004","article-title":"Second-generation antihistamines: Actions and efficacy in the management of allergic disorders","volume":"65","author":"Golightly","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2009.05.017_bib45","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1398-9995.2006.01144.x","article-title":"Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)","volume":"61","author":"Bousquet","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib46","first-page":"497","article-title":"Budesonide and terfenadine, separately and in combination, in the treatment of hay fever","volume":"73","author":"Simpson","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib47","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0091-6749(96)80065-0","article-title":"Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis","volume":"97","author":"Bronsky","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.1984.tb05013.x","article-title":"Astemizole, a potent hista-mine H1-receptor antagonist: Effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels","volume":"18","author":"Howarth","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib49","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/thx.39.9.668","article-title":"Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever","volume":"39","author":"Howarth","year":"1984","journal-title":"Thorax"},{"key":"10.1016\/j.clinthera.2009.05.017_bib50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0091-6749(85)90100-9","article-title":"Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis","volume":"75","author":"Wihl","year":"1985","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 9A","key":"10.1016\/j.clinthera.2009.05.017_bib51","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/S0002-9343(02)01433-X","article-title":"Treatment of allergic rhinitis","volume":"113","author":"Rosenwasser","year":"2002","journal-title":"Am J Med."},{"key":"10.1016\/j.clinthera.2009.05.017_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0091-6749(05)80244-1","article-title":"Perennial allergic rhinitis: Clinical efficacy of a new anti-histamine","volume":"86","author":"Berman","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib53","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0091-6749(88)90164-9","article-title":"H1 Receptor antagonist treatment of chronic rhinitis","volume":"81","author":"Simons","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000053799","article-title":"Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis","volume":"125","author":"Horak","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2009.05.017_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2222.1999.00018.x-i1","article-title":"Clinical assessment of antihistamines in rhinitis","volume":"29","author":"Scadding","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib56","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.1998.tb03798.x","article-title":"Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis","volume":"53","author":"Bachert","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2222.2005.00099.x","article-title":"The role of allergen challenge chambers in the evaluation of antiallergic medication: An international consensus paper","volume":"6","author":"Day","year":"2006","journal-title":"Clin Exp Allergy Rev."},{"key":"10.1016\/j.clinthera.2009.05.017_bib58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1081-1206(10)62044-3","article-title":"Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis","volume":"89","author":"Greiff","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1034\/j.1398-9995.2003.00148.x","article-title":"Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure","volume":"58","author":"Horak","year":"2003","journal-title":"Allerg"},{"key":"10.1016\/j.clinthera.2009.05.017_bib60","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1067\/mai.2002.124657","article-title":"Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit","volume":"109","author":"Horak","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib61","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2222.2004.1904.x","article-title":"Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis","volume":"34","author":"Lee","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib62","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.intimp.2005.05.008","article-title":"Desloratadine and levocetiriz-ine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: A pilot study","volume":"5","author":"Ciprandi","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1081-1206(10)61249-5","article-title":"Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: Results of a singlecenter, placebo-controlled trial","volume":"96","author":"Meltzer","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib64","first-page":"1155","article-title":"The clinical impact of high resolution rhinoma-nometry (HRR): Statistical analysis of 1417 cases","volume":"31","author":"Vogt","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib65","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1034\/j.1398-9995.2001.00082.x","article-title":"Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis","volume":"56","author":"Nayak","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00044011-200121010-00004","article-title":"Efficacy and tolerability of oncedaily 5mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis: Assessment during the spring and fall allergy seasons","volume":"21","author":"Meltzer","year":"2001","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.clinthera.2009.05.017_bib67","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)62086-8","article-title":"Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion","volume":"89","author":"Berger","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1081-1206(10)60914-3","article-title":"Desloratadine therapy for symptoms associated with perennial allergic rhinitis","volume":"96","author":"Kim","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2500\/aap.2006.27.2851","article-title":"Efficacy of desloratadine, 5 mg, compared with fex-ofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis","volume":"27","author":"Berger","year":"2006","journal-title":"Allerg Asthma Proc."},{"key":"10.1016\/j.clinthera.2009.05.017_bib70","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1046\/j.1365-2745.2002.01509.x","article-title":"Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis","volume":"32","author":"Wilson","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1398-9995.2006.01277.x","article-title":"Efficacy of desloratadine in the treatment of allergic rhinitis: A meta-analysis of randomized, double-blind, controlled trials","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2500\/108854199778553046","article-title":"Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis","volume":"20","author":"Casale","year":"1999","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clinthera.2009.05.017_bib73","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1034\/j.1398-9995.2001.00191.x","article-title":"Fexofenadine reduces nasal congestion in perennial allergic rhinitis","volume":"56","author":"Ciprandi","year":"2001","journal-title":"Allerg"},{"key":"10.1016\/j.clinthera.2009.05.017_bib74","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2222.2000.00914.x","article-title":"Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis","volume":"30","author":"van Cauwenberge","year":"2000","journal-title":"Clin Exp Allerg"},{"key":"10.1016\/j.clinthera.2009.05.017_bib75","first-page":"275","article-title":"Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5\u201312 hours postdose, in the environmental exposure unit","volume":"26","author":"Day","year":"2005","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clinthera.2009.05.017_bib76","first-page":"59","article-title":"Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: Duration of effect in subjects with seasonal allergic rhinitis","volume":"25","author":"Day","year":"2004","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clinthera.2009.05.017_bib77","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0091-6749(99)70070-9","article-title":"Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis","volume":"104","author":"Howarth","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib78","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0091-6749(99)70174-0","article-title":"Comparison of the effects of terfenadine with fexofena-dine on nasal provocation tests with allergen","volume":"103","author":"Terrien","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib79","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaci.2004.01.773","article-title":"Levocetirizine better protects than desloratadine in a nasal provocation with allergen","volume":"113","author":"Deruaz","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib80","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1368-5031.2004.0117.x","article-title":"Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU)","volume":"58","author":"Day","year":"2004","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.clinthera.2009.05.017_bib81","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1185\/030079904125003700","article-title":"A direct comparison of the efficacy of antihistamines in SAR and PAR: Randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit-the Vienna Challenge Chamber (VCC)","volume":"20","author":"St\u00fcbner","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2009.05.017_bib82","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1034\/j.1398-9995.2003.00171.x","article-title":"Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites","volume":"58","author":"Potter","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.05.017_bib83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-3038.2005.00216.x","article-title":"Levocetirizine in children: Evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial","volume":"16","author":"de Blic","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib84","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2004.05.070","article-title":"Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis","volume":"114","author":"Bachert","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib85","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1081-1206(10)60693-X","article-title":"Efficacy and safety of cicle-sonide, 200 microg once daily, for the treatment of perennial allergic rhinitis","volume":"98","author":"Meltzer","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib86","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2006.07.050","article-title":"Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis","volume":"118","author":"Ratner","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib87","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2007.02.022","article-title":"Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis","volume":"119","author":"Kaiser","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.05.017_bib88","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2500\/aap2007.28.3033","article-title":"Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: Olopatadine hydrochloride versus mometasone furoate monohydrate","volume":"28","author":"Patel","year":"2007","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clinthera.2009.05.017_bib89","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1081-1206(10)61894-7","article-title":"A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis","volume":"88","author":"Bende","year":"2002","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T13:28:56Z","timestamp":1633613336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0149291809001635"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.05.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}